SAVA- Cassava Sciences Inc

Name: Cassava Sciences Inc Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Cassava Sciences Inc (SAVA) has 9 insiders with recent SEC Form 4 filings, including 12 buys and 0 sells. SAVA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Barry Richard	938.1K	$2.59M	-
Dir	Bir Dawn Carter	53.0K	-	-
Dir	Gravier Pierre	26.5K	-	-
Dir	Scannon Patrick J Md Phd	26.5K	-	-
Dir	O Donnell Michael J	26.5K	-	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 7, 2023	Barry Richard70	Director	Buy	88,841	$25.81	$2,292,823.21	+23.1%	-9.2%	-21.3%
Aug 23, 2022	Kupiec James William	Chief Clinical Dev. Officer	Buy	2,500	$24.44	$61,100.00	New	+28.8%	-31.2%
Aug 23, 2022	Barry Richard70	Director	Buy	36,159	$23.79	$860,222.61	+24.1%	+28.8%	-31.2%
Aug 12, 2022	Schoen Eric	Chief Financial Officer	Buy	2,500	$19.95	$49,875.00	+14.5%	+71.2%	-12.2%
Aug 12, 2022	Robertson Sanford	Director	Buy	100,000	$20.69	$2,069,000.00	+10.8%	+71.2%	-12.2%
Sep 24, 2020	Barbier Remi	President And CEO	Buy	10,000	$9.59	$95,900.00	+0.9%	-	-
Sep 18, 2020	Robertson Sanford	Director	Buy	36,281	$8.92	$323,626.52	+4.1%	-	-
Sep 17, 2020	Schoen Eric	Chief Financial Officer	Buy	12,000	$7.03	$84,380.00	+29.6%	-	-
Sep 17, 2020	Robertson Sanford	Director	Buy	213,719	$6.98	$1,491,758.62	+32.3%	-	-
Dec 31, 2019	Barbier Remi	President And CEO	Buy	100,000	$5.53	$553,000.00	+10.3%	-	-

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC